EDIT vs MKTX
Editas Medicine Inc (EDIT) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
EDIT currently screens at market cap $375.2M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the EDIT and MKTX stock pages for the full models.
Not investment advice.